Bio

J.T. Treadwell has led a variety of STG investments in health care, retail analytics, and marketing services, including AlphaImpactRx (sold to IMS Health), Celtra, Connexity (sold to Taboola.com Ltd.), Extenda Retail, Evidera (sold to PPD), Escalent (formed from the merger of Market Strategies and Morpace), RedSeal, Simmons Research, SPH Analytics (sold to Press Ganey), Symphony Health Solutions (sold to PRA Health Sciences), and Teleca (merged with Symphony Services to become Symphony Teleca, sold to Harman), as well as helping lead investments in GERS Retail Systems (sold to RedPrairie), Intentia (acquired by Lawson), IRI (sold to New Mountain), MSC (sold to Hexagon), Onclusive, and Symphony Marketing Solutions (sold to Genpact), prior to becoming Managing Director. Before joining STG in 2003, J.T. was the Director of Marketing and Strategic Planning at Qiva, a global logistics software firm. Before Qiva, J.T. worked at Bessemer Venture Partners as an associate, where he helped create investments in companies including Worldchain, Nistevo and Trigo Technologies (acquired by IBM) J.T. also served as a consultant at The Boston Consulting Group, where he helped lead numerous strategic marketing and business development deals for clients in the technology, consumer goods and finance sectors. J.T. holds dual Bachelor of Arts degrees in ethics, politics and economics and history from Yale University. He currently serves on the board of directors for Celtra, Escalent, Extenda Retail, Onclusive, and RedSeal.